Why the study?
Does propranolol affect coronary collateral development in response to chronic coronary ischemia in dogs?
Does propranolol affect coronary collateral development in response to chronic coronary ischemia in dogs?
Beta-adrenergic suppression with propranolol does not significantly affect coronary collateral development in response to chronic ischemia in a canine model.
Propranolol shows no effect on collateral development in this canine model; leaves open any impact on human coronary collaterals.
Acute left circumflex coronary artery (LC) occlusion in conscious dogs caused marked ischemia in the myocardium supplied by the occluded artery, as judged by the radioactive microsphere technique for determining blood flow distribution. With the chest open, LC pressure distal to the occlusion fell to 21 +/- 1.9% of aortic pressure. By 8 weeks after gradual LC occlusion with an ameroid constrictor, collateral development had restored coronary blood flow distribution to near-normal under basal conditions and during pacing, at a heart rate of 200 beats/min. The only evidence for ischemia was in the subepicardium within the distribution of the unoccluded left anterior descending artery, which provided the extra collateral blood flow. Distal LC pressure was 70 +/- 1.7% of aortic pressure. Propranolol 160 mg orally every 6 hours for 8 weeks had no detectable effect on coronary collateral development, as judged by blood flow distribution or distal LC pressure. The only significant difference for the propranolol dogs was a slight transmural shift away from the subendocardium in the left anterior descending region.
No takes yet. Share an insight, caveat, or question.
Neill et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: